EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study

Jovana Kuveljic iD, Ana Djordjevic iD, Ivan Zivotic iD, Milica Dekleva, Ana Kolakovic, Maja Zivkovic iD, Aleksandra Stankovic iD, Tamara Djuric iD

Genes · 2024

DOI: 10.3390/genes15101296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Jovana Kuveljic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of B…. Hauptthemen laut MEDLINE: Ventricular Remodeling, Myocardial Infarction, HMGB1 Protein, Transforming Growth Factor beta1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Serbian Ministry of Education, Science and Technological Development, Serbian Ministry of Education, Science and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

After myocardial infarction (MI), adverse left ventricular (LV) remodeling may occur. This is followed by LV hypertrophy and eventually heart failure. The remodeling process is complex and goes through multiple phases. The aim of this study was to investigate the expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO, each involved in a specific step of LV remodeling, in association with the change in the echocardiographic parameters of LV structure and function used to assess the LV remodeling process in the peripheral blood mononuclear cells (PBMCs) of patients six months after the first MI. The expression of selected genes was also determined in PBMCs of controls.

Methods

The study group consisted of 99 MI patients, who were prospectively followed-up for 6 months, and 25 controls. Cardiac parameters, measured via conventional 2D echocardiography, were evaluated at two time points: 3–5 days and 6 months after MI. The mRNA expression six-months-post-MI was detected using TaqMan® technology (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA). Results:HMGB1 mRNA was significantly higher in patients with adverse LV remodeling six-months-post-MI than in patients without adverse LV remodeling (p = 0.04). HMGB1 mRNA was significantly upregulated in patients with dilated LV end-diastolic diameter (LVEDD) (p = 0.03); dilated LV end-diastolic volume index (LVEDVi) (p = 0.03); severely dilated LV end-systolic volume index (LVESVi) (p = 0.006); impaired LV ejection fraction (LVEF) (p = 0.01); and LV enlargement (p = 0.03). It was also significantly upregulated in PBMCs from patients compared to controls (p = 0.005). TGF-β1 and BIRC3 mRNA were significantly lower in patients compared to controls (p = 0.02 and p = 0.05, respectively).

Conclusions

Our results suggest that HMGB1 is involved in adverse LV remodeling six-months-post-MI, even on the mRNA level. Further research and validation are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular RemodelingMyocardial InfarctionHMGB1 ProteinTransforming Growth Factor beta1Cyclin-Dependent Kinase Inhibitor p21Baculoviral IAP Repeat-Containing 3 ProteinADAM17 ProteinHumansMaleFemaleMiddle AgedProspective StudiesAgedEchocardiographyCase-Control Studies

Stichwörter der Autor:innen

ADAM17BIRC3CDKN1AFTOHMGB1TGF-β1gene expressionleft ventricular remodelingmRNAmyocardial infarction

Substanzen

HMGB1 ProteinTransforming Growth Factor beta1HMGB1 protein, humanCyclin-Dependent Kinase Inhibitor p21Baculoviral IAP Repeat-Containing 3 ProteinADAM17 ProteinBIRC3 protein, humanCDKN1A protein, humanADAM17 protein, humanTGFB1 protein, human

Autor:innen und Institutionen

  • Laboratory for Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

ORCID-Profile: Jovana Kuveljic, Ana Djordjevic, Ivan Zivotic, Maja Zivkovic, Aleksandra Stankovic, Tamara Djuric

Förderung

  • the Serbian Ministry of Education, Science and Technological Development
  • Serbian Ministry of Education, Science and Technological Development

Zitieren

APA

Kuveljic, J., Djordjevic, A., Zivotic, I., Dekleva, M., Kolakovic, A., Zivkovic, M., Stankovic, A., & Djuric, T. (2024). Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study. Genes. https://doi.org/10.3390/genes15101296

Vancouver

Kuveljic J, Djordjevic A, Zivotic I, Dekleva M, Kolakovic A, Zivkovic M, et al. Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study. Genes. 2024. doi:10.3390/genes15101296

BibTeX
@article{Kuveljic2024,
  author = {Kuveljic, Jovana and Djordjevic, Ana and Zivotic, Ivan and Dekleva, Milica and Kolakovic, Ana and Zivkovic, Maja and Stankovic, Aleksandra and Djuric, Tamara},
  title = {Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15101296}
}
Kostenlos starten →